The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer

Authors: L S D'Abronzo, S Bose, M E Crapuchettes, R E Beggs, R L Vinall, C G Tepper, S Siddiqui, M Mudryj, F U Melgoza, B P Durbin-Johnson, R W deVere White & P M Ghosh (Source: Oncogene)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2uTy6wQ
via IFTTT